Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Senseonics (NYSE:SENS) in a report published on Friday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $2.00 price target on shares of Senseonics in a report on Wednesday, August 14th.

Senseonics Stock Down 12.5 %

NYSE SENS traded down $0.04 during mid-day trading on Friday, hitting $0.31. The company’s stock had a trading volume of 10,177,989 shares, compared to its average volume of 2,794,578. Senseonics has a twelve month low of $0.30 and a twelve month high of $0.75. The firm has a market capitalization of $165.22 million, a price-to-earnings ratio of -2.37 and a beta of 0.79. The company’s 50 day simple moving average is $0.35 and its 200 day simple moving average is $0.40. The company has a current ratio of 3.11, a quick ratio of 2.89 and a debt-to-equity ratio of 59.17.

Senseonics (NYSE:SENS) last released its quarterly earnings results on Thursday, August 8th. The company reported ($0.03) earnings per share for the quarter, meeting the consensus estimate of ($0.03). Senseonics had a negative net margin of 335.15% and a negative return on equity of 299.69%. The business had revenue of $4.87 million for the quarter, compared to analysts’ expectations of $4.86 million. Analysts anticipate that Senseonics will post -0.13 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the stock. Symmetry Partners LLC bought a new stake in shares of Senseonics in the third quarter valued at approximately $164,000. GSA Capital Partners LLP bought a new position in Senseonics in the 3rd quarter worth $117,000. Virtu Financial LLC purchased a new position in shares of Senseonics in the 1st quarter valued at $162,000. Mirae Asset Global Investments Co. Ltd. raised its position in Senseonics by 30.2% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 909,931 shares of the company’s stock worth $483,000 after acquiring an additional 211,128 shares during the period. Finally, State Board of Administration of Florida Retirement System acquired a new stake in Senseonics in the first quarter valued at approximately $91,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.